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Abstract
 
CD1b and CD1c are antigen-presenting molecules that mediate recognition of bacterial lipids
by T cells, but it is currently not known whether these two molecules are redundant or are
specialized to perform different immunological functions. Here, we show that the distribution
of CD1c in human dendritic cells was characterized by a high ratio of cell surface to intracellu-
lar molecules, whereas CD1b showed a reciprocal pattern of distribution. In contrast to the ac-
cumulation of CD1b in lysosomal major histocompatibility complex class II compartments, in-
tracellular CD1c molecules accumulated in other endocytic compartments, most likely early
and late endosomes. Deletion of the cytoplasmic tail of CD1c, containing a tyrosine-based in-
ternalization motif, abolished most of its intracellular localization. Functional studies using T
cells specific for defined lipid antigens revealed that in contrast to CD1b-mediated antigen pre-
sentation, antigen presentation by CD1c was resistant to drugs inhibiting endosomal acidifica-
tion and was independent of endosomal localization of CD1c. Taken together, these results
support the hypothesis that CD1b and CD1c are specialized to survey the lipid content of dif-
ferent intracellular compartments.
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Introduction
 
The human CD1 locus encodes five nonpolymorphic CD1
genes, four of which are known to encode expressed pro-
teins related in structure and evolution to MHC class I
molecules (1). These proteins, designated CD1a, CD1b,
CD1c, and CD1d, are expressed on the surfaces of den-
dritic cells (DCs), and all have been implicated in the pre-
sentation of specific lipid and glycolipid ligands to T cells
(2–5). Several mycobacterial lipids presented by CD1b have
been identified (6, 7), and recently the first lipid presented
by CD1c has also been characterized as a mycobacterial
glycolipid (8). T cell responses to a semisynthetic analogue
of this CD1c-presented lipid were elevated in the blood of
 
human subjects previously infected with 
 
Mycobacterium tu-
berculosis
 
 compared with naive control subjects, underscor-
ing the potential importance of the CD1 system in the im-
mune response to pathogens (8). The genomes of a variety
of mammals, including humans, sheep, rabbits, guinea pigs,
and rhesus macaques, contain multiple copies of CD1 genes
that encode diversified forms of CD1 genes (6). The forces
driving and maintaining this diversification of CD1 genes
in various mammals are not known, but we have previously
speculated that this may be due at least in part to the spe-
cialization of different CD1 proteins to perform subtly but
significantly different roles in the immune response to
pathogens encountered by these different species (9).
To evaluate the hypothesis of functional specialization of
CD1 isoforms, we have studied the intracellular distribu-
tion and antigen-presenting properties of the human CD1c
protein compared with the previously documented features
of CD1b. Studies on the intracellular localization of CD1b
demonstrate that this protein is prominently found in late
endosomal and lysosomal compartments (10). Localization
of CD1b to these intracellular compartments is dependent
 
Address correspondence to Steven A. Porcelli, Department of Microbiol-
ogy and Immunology, Albert Einstein College of Medicine, Rm. 416
Forchheimer Bldg., 1300 Morris Park Ave., Bronx, NY 10461. Phone:
718-430-3228; Fax: 718-430-8711; E-mail: porcelli@aecom.yu.edu 
282
 
Distinct Trafficking and Function of CD1 Isoforms
 
on its nine–amino acid cytoplasmic tail, which contains a
tetrapeptide that conforms to a tyrosine-based targeting
motif denoted as YxxZ (where Y is tyrosine, x represents
any amino acid, and Z is a bulky hydrophobic amino acid)
(11). The localization of CD1b to late endosomes and lyso-
somes is consistent with the finding that presentation of
lipid antigens by CD1b is in most cases highly sensitive to
agents that interfere with normal endosomal acidification
(12). In the current study, we demonstrate significantly dif-
ferent intracellular localization and antigen presentation
properties for CD1b and CD1c. Our results provide sup-
port for the hypothesis that the diversification of CD1 pro-
teins into multiple isoforms reflects their specialization for
presentation of different subsets of antigens accumulating in
distinct intracellular compartments. This may help to ex-
plain the extensive duplication and diversification of CD1
proteins observed in humans and other mammalian species.
 
Materials and Methods
 
Cell Lines, Antigens, and Antibodies.
 
T cell lines DN1 (12),
CD8.1 (2, 8), and SP-F14 (13) have been described. An extract of
total lipids of 
 
M
 
.
 
 tuberculosis
 
 strain H37Ra was prepared as de-
scribed previously (2, 4). Tetanus toxoid was obtained from the
Massachusetts Department of Public Health Laboratory (Jamaica
Plain, MA). The 15-mer tetanus toxoid peptide used in this study
corresponded to residues 947–961 of tetanus toxin (FNNFTVSF-
WLRVPKV). HeLa cells were obtained from the American Type
Culture Collection. C1R cells were obtained from P. Cresswell
(Yale University, New Haven, CT). Immature monocyte-derived
DCs were obtained by culturing the adherent fraction of normal
human PBMCs in the presence of GM-CSF and IL-4 for 3 d (5).
Antibodies used in this study that have been described previously
(11, 14) were BCD1b3 (anti-CD1b, IgG1), F10/21A3 (anti-
CD1c, IgG1), anti-CD1b rabbit antiserum R3, P3 (IgG1 con-
trol), and the rabbit anti–human lysosome-associated membrane
protein 1 (Lamp-1) antiserum. Other antibodies used were L161
(anti-CD1c, IgG1; Immunotech), W6/32 (anti–HLA-A,-B,-C;
American Type Culture Collection), L243 (anti–HLA-DR;
American Type Culture Collection), HC-10 (anti–HLA-B,-C;
gift of Dr. H. Ploegh, Harvard Medical School, Boston, MA),
and H68.4 (anti-transferrin receptor [TfR]; gift of Dr. S. Amig-
orena, Institut Curie, Paris, France). Commercially available anti-
bodies and secondary labeling reagents used were: CY3- and
FITC-conjugated goat F(ab
 
9
 
)
 
2
 
 anti–mouse Ig, CY3- or FITC-
conjugated goat F(ab
 
9
 
)
 
2
 
 anti–rabbit IgG (Jackson Immunore-
search Laboratories), horseradish peroxidase (HRP)-conjugated
protein A or goat anti–rabbit IgG antibody (Zymed Laboratories),
rabbit anti–mouse IgG (Dako), and 10-nm gold–conjugated pro-
tein A (from G. Posthuma, University of Utrecht, Utrecht, The
Netherlands).
 
Construction of CD1c Mutants and Transfections.
 
Plasmids for
expression of the wild-type CD1c protein (CD1c.WT) and
CD1b have been described (15). A cDNA encoding the tail-
deleted form (CD1c.TD) was generated by PCR using CD1c.WT
as template DNA. Primers used were 5
 
9
 
-CTCAACTC-
TACGTCTTTGTTTCG-3
 
9
 
 (bases 
 
z
 
570–590 of the human T
cell lymphotropic virus [HTLV] LTR region from the vector
pSR
 
a
 
-NEO) and 5
 
9
 
-TCGGGATCCTACTTCTTAAACCAT-
AACACAAGGAC-3
 
9
 
 (minus strand 3
 
9
 
 end of CD1c). The am-
plified fragment was cloned and sequenced, and the Xho1 to
 
BamH1 region was inserted into pSR
 
a
 
-NEO. Stable transfec-
tants were produced by electroporation (C1R cells) and the
CaPO
 
4
 
 method (HeLa cells) as described (11). For transient trans-
fection, HeLa cells were transfected with 1.5 
 
m
 
g of each plasmid
DNA using Lipofectamine™ lipid reagent (Life Technologies).
 
Flow Cytometry and Microscopy Studies.
 
Flow cytometry and
standard immunofluorescence or confocal microscopy were done
as described previously (11, 16). Samples were mounted for fluo-
rescence microscopy using the ProLong™ Antifade kit (Molecu-
lar Probes).
For immunoelectron microscopy, ultrathin cryosections of im-
mature DCs were stained with either BCD1b3 (anti-CD1b) or
L161 (anti-CD1c) followed by a rabbit anti–mouse Ig antibody
revealed by staphylococcal protein A conjugated to 10-nm gold
particles. Procedures used for preparation of electron microscopy
(EM) samples and for quantitative analysis of immunogold stain-
ing (11) have been described previously.
 
Subcellular Fractionation.
 
Immature DCs were radiolabeled
with a mixture of [
 
35
 
S]methionine and [
 
35
 
S]cysteine (NEN Life
Science Products) at 100 
 
m
 
Ci/ml for 22 h. Subsequent Percoll
fractionation, enzymatic assays, and immunoblotting were per-
formed as described (17). Membranes of the Percoll fractions
were treated with 200 U of PNGase F (New England Biolabs,
Inc.) for 12 h to deglycosylate CD1 molecules before immuno-
blotting. Dilutions for antibodies were: TfR (H68.4; 1:10 dilution
of hybridoma culture supernatant), MHC class I (HC-10; 1:200
ascites), Lamp-1 (93B1; 1:1,500 rabbit serum), or CD1b (R3;
1:1,000 rabbit serum). Primary antibodies were revealed by HRP-
coupled protein A or goat anti–rabbit IgG antibodies (1:40,000
dilution) and incubation with the HRP substrate to induce
chemiluminescence (Renaissance™; NEN Life Science Prod-
ucts), which was detected by autoradiography (Biomax light
films; Eastman Kodak Co.). To determine the total protein distri-
bution, 10 
 
m
 
l of each fraction was counted in a 
 
b
 
-scintillation
counter. For immunoprecipitations, 500 
 
m
 
l of the fractions was
added to 1 ml of lysis buffer (0.5% Triton X-100) for 30 min, fol-
lowed by a 30-min centrifugation at 14,000 rpm in a microfuge.
Proteins were sequentially immunoprecipitated using the anti-
CD1c (F10/21A3), anti-CD1b (BCD1b3), anti–MHC class II
(L243), and anti–MHC class I (W6/32) antibodies (5 
 
m
 
g bound
to protein G–Sepharose beads; Amersham Pharmacia Biotech).
The CD1b and CD1c immunoprecipitates were treated with
PNGase F (50 U) for 12 h at 37
 
8
 
C. Samples were boiled, re-
duced, and separated by SDS-PAGE. Dried gels were incubated
with an MR film (Eastman Kodak Co.) and a Dupont intensify-
ing screen at 
 
2
 
80
 
8
 
C for 6 h to 3 d.
 
Antigen Presentation Assays.
 
Cytolytic T cell assays were done
as described (12, 18). Determination of the kinetics of antigen
presentation by CD1c compared with MHC class II was done us-
ing measurement of intracellular Ca
 
2
 
1
 
 mobilization as the readout
for T cell activation. Immature DCs were incubated for various
times with either 10 
 
m
 
g/ml of total lipid extract from 
 
M
 
.
 
 tuberculo-
sis
 
, 0.1 mg/ml of intact tetanus toxoid protein, or 75 ng/ml of
an antigenic 15-mer peptide from tetanus toxoid, and then im-
mediately placed in an ice water bath. T cell lines (CD8.1 to as-
sess antigen presentation by CD1c, and SP-F14 to assess presenta-
tion by MHC class II) were incubated with 1.5 
 
m
 
g/ml Indo-1 for
40 min at 37
 
8
 
C, washed, aliquoted, and applied to a flow cytom-
eter (MO-FLO cytometer; Cytomation) for 30 s to determine
the baseline fluorescence at 405 vs. 485 nm of unstimulated Indo-
1–loaded T cells after excitation with an argon laser at 364 nm.
Subsequently, the Indo-1–loaded T cells were quickly pelleted
together in a microfuge with equal numbers of immature DCs 
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ing (End/PM) was determined (right), and again the mean of these ratios
was three- to fourfold higher for CD1b compared with CD1c (
 
P
 
 5
 
0.0002). The plasma membrane gold particle count was 404 for CD1b and
310 for CD1c labeling on surface areas of 615 and 544 U, respectively.
Similarly, endosomal gold particles counted were 231 for CD1b and 27 for
CD1c on surface areas of 535 and 262 U, respectively.
 
Figure 1.
 
Intracellular distribution of CD1b versus CD1c in immature
DCs. (A) Confocal microscopy of immature DCs that were fixed, perme-
abilized, and double labeled with CY3-conjugated anti-CD1c mAb (F10/
21A3) and CY2-conjugated anti-CD1b mAb (BCD1b3). Single channel
analysis is shown for CD1c (left) and for CD1b (middle). The overlay
(right) revealed vesicles containing both CD1b and CD1c (yellow), and
vesicles containing only CD1c (red) or CD1b (green) (arrowheads). Bars, 2
 
m
 
m. (B) Electron micrographs of cryosections of immature DCs labeled
with CD1b-specific mAb BCD1b3 (top) or CD1c-specific mAb L161
(bottom). CD1b labeling was found at the PM, in endosomes (arrows) and
MIICs, but not in mitochondria (m) or nuclei (n). Expression of CD1c was
restricted to PM and endosomes (arrows) and was not found in MIICs (ar-
rowhead). Bar, 0.5 
 
m
 
m. (C) Quantitation of the CD1b or CD1c staining in
immunoelectron micrographs. The mean PM expression (the number of
gold particles [Q] over a unit length of membrane [p]; left) for CD1b and
CD1c was not significantly different (
 
P
 
 5 
 
0.48; for CD1b, 
 
n 
 
5 
 
11, and for
CD1c,
 
 n 
 
5 
 
10). Quantitation of endosomal (End) distribution (including
lysosomes and MIICs) of the CD1 proteins in the same samples revealed
fourfold more CD1b labeling compared with CD1c (
 
P
 
 5 
 
0.0001; middle).
In addition, for each individual section the ratio of endosomal to PM stain-
 
that had been incubated at 37
 
8
 
C for various periods of time with
antigen. After incubation of the pelleted cells together for 1.5 min
at 37
 
8
 
C, the samples were resuspended in 500 
 
m
 
l of RPMI 1640
medium and applied to the flow cytometer for quantification of
the increase in free [Ca
 
2
 
1
 
]
 
i
 
 as monitored by the change in the ra-
tio of fluorescence emissions at 405 vs. 485 nm (Indo-1 index).
 
Results and Discussion
 
Different Distribution of CD1b and CD1c in Immature DCs.
 
Initially, the distribution of CD1b and CD1c in immature
DCs derived from PBMCs was analyzed by dual immu-
nofluorescence staining and confocal microscopy. This
showed strong cell surface and weaker, scattered punctate
intracellular staining for CD1c (Fig. 1 A, left). This staining
pattern was the inverse of that observed for CD1b, which
had strong intracellular staining and relatively weaker cell
surface staining (Fig. 1 A, middle). The overlay of CD1c
and CD1b staining revealed vesicles containing only CD1c
(red) or CD1b (green), and also vesicles containing both
CD1 proteins (yellow) (Fig. 1 A, right; arrowheads). A de-
tailed immunofluorescence analysis was also performed on
CD1b- and CD1c-transfected HeLa cells and showed that
whereas CD1b mainly colocalizes with Lamp-1–positive
compartments, CD1c was mainly found in compartments
positive for the TfR (data not shown). To assess the subcel-
lular distribution of CD1b and CD1c more precisely, im-
munogold labeling of ultrathin cryosections of immature
DCs and EM were performed. CD1b was found on the
plasma membrane (PM), in endosomes, and in lysosomal
MHC class II compartments (MIICs; Fig. 1 B, top). Inter-
estingly, although very well expressed at the PM, fewer en-
dosomal structures that labeled for CD1c could be found
and CD1c labeling was totally absent from MIICs (Fig. 1
B, bottom). A quantitative EM analysis revealed that the
mean cell surface expression was not significantly different
for CD1b and CD1c (Fig. 1 C, left), which was consistent
with FACS
 
®
 
 analysis showing equal cell surface expression
of CD1b and CD1c (not shown). In contrast, the mean
value for the amount of endosomal labeling (including
MIIC) was about four times higher for CD1b compared
with CD1c (Fig. 1 C, middle), and the mean for the ratio
of endosomal to PM staining determined for each individ-
ual section revealed a similar fourfold increased level of in-
tracellular CD1b staining relative to CD1c (Fig. 1 C, right).
Altogether, these results demonstrated that the relative dis-
tributions of CD1b and CD1c in immature DCs were sig-
nificantly different, suggesting different pathways of intra-
cellular trafficking for these proteins. 
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To analyze this difference in distribution on a larger
population of cells, we used a biochemical approach based
on subcellular fractionation by Percoll gradients to isolate
MIICs. Since no antibody for detection of CD1c by im-
munoblotting was available, the distribution of CD1c in
these Percoll fractions was determined by specific immuno-
precipitation. Therefore, immature DCs were labeled for
22 h with radioactive methionine/cysteine to achieve
steady state labeling of cellular proteins. Initial characteriza-
tion of the Percoll gradients was carried out using enzy-
matic assays or Western immunoblotting to localize specific
markers of various subcellular compartments, which dem-
onstrated that lysosomal compartments were efficiently
separated from the PM, early and late endosomes, and the
endoplasmic reticulum (Fig. 2 A). Next, the distribution of
CD1b and CD1c in the Percoll gradient fractions was ana-
lyzed and compared with MHC class I and MHC class II
by immunoprecipitation. This revealed that the distribu-
tion of CD1b was similar to that of MHC class II mole-
cules, with one peak in the lysosomal fractions 3 and 4 and
a second peak in fractions 8 and 9 containing PM and en-
dosomes (Fig. 2 B). In fact, CD1b accumulated even more
prominently in lysosomes than MHC class II molecules. In
contrast, CD1c molecules were not found in the lysosomal
fractions and accumulated in fractions 8 and 9, very similar
to the distribution of MHC class I molecules.
 
Cytoplasmic Tail Dependence of Endosomal Localization of
CD1c.
 
The endosomal localization of CD1b is dependent
on a tyrosine-based motif (YQ NI) contained within its cy-
toplasmic tail (10, 11). The cytoplasmic tail of CD1c con-
tains a very similar four–amino acid tyrosine-based motif
with only a single amino acid difference (N to D at posi-
tion Y
 
1
 
2) compared with the CD1b motif. To analyze the
importance of the cytoplasmic tail of CD1c in its endoso-
mal localization, a tail-deleted molecule (CD1c.TD) was
stably expressed by transfection in HeLa cells. A compar-
ison of the staining pattern of the wild-type CD1c pro-
tein (CD1c.WT) and CD1c.TD by immunofluorescence
revealed striking differences between these molecules.
Whereas a clear punctate intracellular staining pattern was
observed for CD1c.WT (Fig. 3 A, top) consistent with an
endosomal localization of a substantial fraction of these
molecules, CD1c.TD showed prominent cell surface stain-
ing and almost no punctate intracellular staining (Fig. 3 A,
bottom). Vesicular staining with an antiserum specific for
Lamp-1 was equivalent in both transfectants (data not
shown).
As a second approach to assess the role of the cytoplas-
mic tail of CD1c in its intracellular localization, we exam-
ined the effect of cytoplasmic tail deletion on cell surface
expression of CD1c by FACS
 
®
 
. HeLa cells were transiently
transfected with equimolar quantities of plasmid encoding
CD1c.WT or CD1c.TD or with vector alone, and 2 d later
the cell surface expression of CD1 molecules was analyzed
by FACS
 
®
 
. This showed that the tail-deleted form of
CD1c was expressed at threefold higher levels at the cell
surface compared with CD1c.WT (Fig. 3 B), consistent
with its failure to accumulate in intracellular compartments
Figure 2. Accumulation of CD1b but not CD1c in lysosomal com-
partments and MIICs. Immature DCs were labeled for 22 h with radioac-
tive [35S]methionine/cysteine, homogenized, and subsequently fraction-
ated by Percoll gradient centrifugation. (A) The relative distribution of
the enzymes alkaline phosphodiesterase (APDE, n) and b-hexosamini-
dase (B-HEX, d) was determined to monitor the presence of plasma
membrane or lysosomes in the Percoll gradient fractions, respectively.
The distribution of total proteins (j) is also shown. Membranes of each
fraction were isolated and deglycosylated with PNGase F before immu-
noblotting with antibodies specific for TfR, Lamp-1, MHC class I, and
CD1b and detection by chemiluminescence and autoradiography. (B)
The distribution of MHC class II, MHC class I, CD1b, and CD1c mole-
cules in Percoll fractions was compared by immunoprecipitation. Proteins
from the postnuclear supernatant (PNS) were immunoprecipitated with
either the specific antibody (Sp) or an isotype control antibody (Co).
Only the CD1b and CD1c molecules were deglycosylated with PNGase
F before SDS-PAGE. 
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and subsequent redistribution to the cell surface. Thus, as
previously shown for CD1b, the cytoplasmic tail was nec-
essary for the endosomal localization of CD1c.
 
Characterization of the CD1c-mediated Lipid Antigen Presen-
tation.
 
To determine if the different intracellular distribu-
tion of CD1b and CD1c molecules was linked to differ-
ences in antigen presentation function, we analyzed the
dependence on endosomal acidification of presentation of
mycobacterial lipids by these molecules. Two different ly-
sosomotropic agents, chloroquine and concanamycin B,
were used at increasing doses to determine the requirement
for endosomal acidification for exogenous lipid antigen
presentation by CD1b- or CD1c-transfected B lympho-
blastoid cells (CIR). Both agents produced a complete in-
hibition of CD1b-mediated antigen presentation, whereas
CD1c-mediated presentation was only slightly affected by
concanamycin B at high doses and not at all by chloroquine
(Fig. 4 A). The differential effect of chloroquine on antigen
presentation by CD1b or CD1c could also be reproduced
using immature DCs as APCs in this in vitro system, ex-
cluding the possibility that this effect was cell line specific
(data not shown). This difference in dependence on endo-
somal acidification could be interpreted as evidence that
the association of lipids with CD1c either occurred directly
at the PM or in early endosomes, which are known to have
a neutral pH. The classic experiment to distinguish be-
tween the association of an antigen and its presenting mol-
ecule at the PM as opposed to an intracellular compartment
is to fix the APC and subsequently analyze its capacity to
present an exogenously added antigen. However, this ap-
proach was not successful for this study for technical rea-
sons, most likely due to the CD1c–lipid complex at the cell
surface being extremely sensitive to fixation by a variety of
different agents (data not shown).
To circumvent this technical problem, we took advan-
tage of the tail deletion effect on the intracellular distribu-
tion of CD1c in HeLa cells (Fig. 3 B) and compared the ca-
pacity of the wild-type and tail-deleted forms of CD1c to
Figure 3. Cytoplasmic tail dependence of the endosomal distribution of CD1c. (A) Transfected
HeLa cells stably expressing CD1c.WT (top) and CD1c.TD (bottom) were fixed, permeabilized,
and labeled with the specific anti-CD1c mAb F10/21A3. Bars, 10 mm. (B) HeLa cells were tran-
siently transfected with equimolar quantities of plasmid encoding CD1c.WT, CD1c.TD, or with
vector alone. After 48 h, intact cells were analyzed by flow cytometry for surface expression of
CD1c. Results shown are mean values of the mean fluorescence intensity (MFI) for three indepen-
dent samples of both transfections.
Figure 4. Characterization of
CD1c-mediated lipid antigen
presentation. (A) C1R B lym-
phoblastoid cells stably trans-
fected with CD1b (circles) or
CD1c (squares) were labeled
with  51Cr and coincubated over-
night at a constant antigen con-
centration (CD1b: 60 mg/ml
mycolic acid; CD1c: 13 mg/ml
of  M. tuberculosis total lipid ex-
tract) and various concentrations
of either chloroquine (0.02–62.5
mM; filled symbols) or concana-
mycin B (0.02–62.5 nM; open
symbols). These target cells were
then analyzed by a standard 4-h
chromium release cytolysis assay
as described in Materials and
Methods using the CD1c-spe-
cific T cell line CD8.1 and the
CD1b-specific T cell line DN1.
(B) HeLa cells transfected with
vector alone (mock; m) or with
CD1c.WT (j) or CD1c.TD (d)
plasmid for stable expression
were labeled with 51Cr. These
cells were incubated overnight
with increasing doses of antigen
(M. tuberculosis total lipid extract),
then harvested, washed once
with PBS, and combined with
the T cell line CD8.1 at an E/T
ratio of 15:1 for 4 h. (C) Imma-
ture DCs were incubated with
antigens presented by CD1c (10 mg/ml of total lipid extract from M. tuber-
culosis containing the Hex-1–PIP antigen) or MHC class II (0.1 mg/ml
tetanus toxoid protein [TTprot] or 75 ng/ml of an antigenic 15-mer pep-
tide from tetanus toxoid [TTpep]) for various times. The presentation of
antigens was measured by the increase in [Ca21]i in the T cells specific for
the CD1c-presented lipid antigen Hex-1–PIP (j) or MHC class II–pre-
sented TTpep (m) or TTprot (d), and was expressed as a percentage of
maximal Indo-1 index after the subtraction of background values (T cells
plus APCs without antigen). Specific T cell lines used were CD8.1 for
CD1c and SP-14 for MHC class II. Results shown are representative of
three independent experiments. 
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present lipid antigens. Surprisingly, this revealed that
CD1c.TD had no detectable deficiency in the presentation
of the mycobacterial glycolipid antigen hexose 1–phospho-
isoprenoid (Hex-1–PIP) to CD1c-restricted T cells (Fig. 4
B). This result was confirmed using CD1c.WT- or
CD1c.TD-expressing CIR cells as APCs (data not shown).
These results, along with the absence of an effect of lysoso-
motropic agents on antigen presentation by CD1c, sug-
gested that association of this glycolipid antigen with CD1c
occurred at the cell surface rather than in an endosomal
compartment.
A second approach to examine this question was based
on the premise that the kinetics of presentation for an anti-
gen that associates with its presenting molecule at the cell
surface (like MHC class II with antigenic peptides) should
be more rapid than antigen presentation requiring internal-
ization and processing by the APC (like presentation of in-
tact protein antigens by MHC class II). Therefore, the ki-
netics of presentation of a mycobacterial glycolipid antigen
(Hex-1–PIP) by CD1c was compared with the kinetics of
MHC class II–restricted antigen presentation after incuba-
tion of the APCs with either intact tetanus toxoid protein
antigen (TTprot) or an antigenic 15-mer peptide derived
from this protein (TTpep). The time required to achieve
50% of the maximal response (
 
t
 
max1/2
 
) to lipid antigen pre-
sentation by CD1c was 
 
z
 
8 min, which was similar to that
of the TTpep presentation by MHC class II, with a 
 
t
 
max1/2
 
of 5 min. In contrast, the 
 
t
 
max1/2 
 
of the TTprot presentation
by MHC class II was substantially longer, at 
 
z
 
39 min (Fig.
4 C). These results were consistent with the idea that the
association of lipid antigen with CD1c occurred at or near
the cell surface, since the kinetics of presentation was much
more similar to that of MHC class II–mediated presenta-
tion of exogenous peptides than to the kinetics of presenta-
tion of an intact protein antigen. In contrast, a separate se-
ries of experiments showed no difference in the kinetics of
presentation of the lipid antigen mycolic acid by CD1b
compared with that of intact tetanus toxoid presentation by
MHC class II (data not shown), consistent with the pro-
posed association of lipid antigens with CD1b in a late en-
docytic compartment.
In summary, the differences in subcellular distribution of
CD1b and CD1c correlated with marked differences in the
functional properties of these molecules in antigen presen-
tation. One major difference observed between the CD1b-
and CD1c-mediated antigen presentation in this study was
related to their requirement for endosomal acidification for
normal expression of antigen-presenting function (Fig. 4
A). Consistently, only CD1b localizes to the most acidic
endocytic compartments, whereas CD1c accumulates on
the cell surface and in early endosomes (Figs. 1 and 2). Al-
though the Hex-1–PIP lipid seemed to associate with
CD1c at the cell surface in our in vitro assay, the intracellu-
lar localization of CD1c may very well be important for the
presentation of other CD1c-restricted lipid antigens that
have yet to be defined or during the course of a live myco-
bacterial infection. In fact, preliminary results show that
CD1c was found to colocalize with mycobacteria in phago-
lysosomes (data not shown), and studies currently in progress
are assessing the presentation of CD1c-restricted lipids in
the context of intracellular infection of APCs.
The recently identified CD1c-presented glycolipid Hex-
1–PIP is unique among the known CD1-presented anti-
gens in that its hydrophobic moiety contains only a single
alkyl chain, in contrast to the dual or branched alkyl chains
found in all of the previously described CD1b-presented
lipid antigens (6, 8). Although data on the spectrum of lip-
ids presented by CD1c are still extremely limited, it is in-
triguing to speculate that CD1b and CD1c molecules may
predominantly present two structurally different classes of
lipids, in that they contain either a dual or a single alkyl
chain motif, respectively. In this context, the finding that
lipids can be sorted to various sites within the cell accord-
ing to the specific structure and composition of their alkyl
tails is of great interest (19). Although a recent study ob-
served a similar resistance to inhibitors of endosomal acidi-
fication for presentation of a putative lipid antigen by an-
other human CD1 molecule, CD1a (20), the CD1a ligand
has not yet been identified and therefore no conclusions
about a structural analogy to the CD1c ligand are possible.
Taken together, the data currently available on the intra-
cellular localization of three human CD1 proteins (CD1a,
CD1b, and CD1c) are consistent with each of these being
focused predominantly at a different level within the en-
docytic system, supporting the hypothesis that the different
isoforms of CD1 expressed by a single individual have
evolved complementary functions that are to survey the
lipid content of different subcellular compartments (9). An
important goal for future studies will be to determine
whether the specific antigens presented by each of these
different CD1 proteins are also distributed within APCs in
a pattern that overlaps the localization and trafficking pat-
terns of the particular CD1 protein that presents them.
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